Numerai Gp LLC Tarsus Pharmaceuticals, Inc. Transaction History
Numerai Gp LLC
- $530 Billion
- Q1 2025
A detailed history of Numerai Gp LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Numerai Gp LLC holds 14,459 shares of TARS stock, worth $594,987. This represents 0.14% of its overall portfolio holdings.
Number of Shares
14,459
Previous 18,668
22.55%
Holding current value
$594,987
Previous $1.03 Billion
28.14%
% of portfolio
0.14%
Previous 0.28%
Shares
2 transactions
Others Institutions Holding TARS
# of Institutions
205Shares Held
44.1MCall Options Held
19.9KPut Options Held
7.6K-
Rtw Investments, LP New York, NY3.32MShares$136 Million2.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$134 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.61MShares$107 Million6.87% of portfolio
-
Jennison Associates LLC2.47MShares$102 Million0.06% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$101 Million8.19% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.1B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...